Opportunity Information: Apply for PAR 20 302
The Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) funding opportunity (NIH, PAR-20-302; CFDA 93.395) supports research that looks closely at how tobacco prevention and control policies can reduce unequal burdens of tobacco use and secondhand smoke exposure across different populations in the United States. The central idea is to fund studies that either observe real-world policy impacts or test interventions tied to policy implementation, with a clear emphasis on reducing disparities. By focusing on state and local policy environments, the program aims to generate practical, policy-relevant evidence that can be used to improve public health outcomes where inequities are most pronounced.
A key feature of this announcement is its specific focus on innovative state and local tobacco control policies. Projects are expected to examine how these policies are designed, adopted, implemented, enforced, and experienced by communities, particularly groups that face higher rates of tobacco use or greater exposure to secondhand smoke. The long-term objective goes beyond reducing tobacco use in general; it is explicitly tied to reducing disparities in tobacco-related cancers and advancing health equity for all populations. In other words, the research should help explain not only whether a policy works, but whether it works equitably, for whom, and under what real-world conditions.
The FOA allows for a wide range of scientific approaches under the R01 mechanism, including both observational studies (for example, evaluations of policy changes over time, natural experiments, surveillance-based analyses, or comparative policy studies across jurisdictions) and intervention research (for example, strategies that strengthen policy uptake, enforcement, compliance, or equitable implementation). The "Clinical Trial Optional" designation means applicants may propose clinical trials if appropriate, but a clinical trial is not required. The emphasis remains on tobacco control policy and its effects on disparities in use and secondhand smoke exposure rather than on clinical treatment per se.
Applicants intending to submit health economics-focused projects are encouraged to consult NIH guidance in NOT-OD-16-025 to ensure alignment with NIH priorities in health economics research. This is essentially a reminder that economic analyses (such as taxation effects, pricing policies, cost-effectiveness, health care cost impacts, or economic equity impacts) should be framed in ways that match NIH expectations for rigor and mission relevance.
Eligibility is broad and includes many types of domestic organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other tribal organizations; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); small businesses; and other organizations. The FOA also highlights additional eligible applicant categories that are often central to equity-focused policy research, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
At the same time, the opportunity places firm limits on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by NIH Grants Policy) are not allowed. This makes the program strongly U.S.-focused in both research setting and organizational participation, consistent with its goal of addressing tobacco-related disparities within the United States.
Administratively, the opportunity is offered by the National Institutes of Health as a discretionary grant program using the R01 funding instrument. The source data lists an original closing date of 2023-09-07 and a creation date of 2020-09-04. An award ceiling and expected number of awards are not specified in the provided listing, which often means applicants need to rely on NIH standard R01 budgeting rules and any institute- or application-specific guidance for practical expectations.
Overall, this FOA is designed for researchers and organizations that want to produce strong, actionable evidence on how tobacco control policies at the state and local level can be leveraged or improved to reduce inequities in tobacco use and secondhand smoke exposure, with the broader public health payoff of lowering disparities in tobacco-related cancer outcomes and supporting health equity.Apply for PAR 20 302
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395.
- This funding opportunity was created on 2020-09-04.
- Applicants must submit their applications by 2023-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the purpose of the Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) opportunity?
This funding opportunity supports research on how tobacco prevention and control policies can reduce unequal burdens of tobacco use and secondhand smoke exposure across different populations in the United States. The emphasis is on producing practical, policy-relevant evidence that helps explain whether policies work, whether they work equitably, for whom, and under what real-world conditions.
What is the official funding opportunity identifier?
The opportunity is listed as NIH PAR-20-302 with CFDA 93.395.
What types of outcomes or impacts is the program trying to influence?
The program focuses on reducing disparities in tobacco use and secondhand smoke exposure, with a longer-term objective of reducing disparities in tobacco-related cancers and advancing health equity across populations.
What kinds of research projects fit this FOA?
The FOA supports studies that observe real-world policy impacts or test interventions tied to policy implementation. Projects are expected to focus on state and local tobacco control policies and examine how policies are designed, adopted, implemented, enforced, and experienced by communities, especially populations facing higher tobacco-related burdens.
Are clinical trials required?
No. The FOA is labeled "Clinical Trial Optional," meaning a clinical trial may be proposed if appropriate, but it is not required.
If clinical trials are optional, what is the main focus instead?
The central focus is tobacco control policy and its effects on disparities in tobacco use and secondhand smoke exposure, rather than clinical treatment.
What study designs or approaches are allowed under this R01?
A wide range of approaches are allowed, including observational studies (such as evaluations of policy changes over time, natural experiments, surveillance-based analyses, and comparative policy studies across jurisdictions) and intervention research (such as strategies to strengthen policy uptake, enforcement, compliance, or equitable implementation).
Does the FOA emphasize any particular policy level or setting?
Yes. The FOA emphasizes innovative state and local tobacco control policies and aims to generate evidence relevant to those policy environments.
What does it mean to examine policies as they are "designed, adopted, implemented, enforced, and experienced"?
It means projects should look beyond whether a policy exists and assess real-world policy processes and conditions, including how policies come to be, how they are put into practice, how enforcement and compliance work, and how communities experience the policy in practice, particularly in populations most affected by tobacco-related inequities.
Is health equity explicitly required as part of the research focus?
Yes. A clear emphasis is placed on reducing disparities and advancing health equity, including understanding whether policy effects are equitable across different populations.
Are health economics studies allowed?
Yes. Health economics-focused projects are mentioned as an allowed area, with encouragement to consult NIH guidance in NOT-OD-16-025 to ensure alignment with NIH priorities in health economics research.
What kinds of economic analyses does the FOA suggest might be relevant?
Examples referenced include analyses related to taxation effects, pricing policies, cost-effectiveness, health care cost impacts, and economic equity impacts, as long as they are aligned with NIH expectations for rigor and mission relevance.
Who can apply for this funding?
Eligibility is broad for domestic applicants. Eligible applicants include many types of U.S.-based organizations and governmental entities, including governments (state, county, city/township), special districts, independent school districts, public and private institutions of higher education, tribal governments and tribal organizations, public/Indian housing authorities, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and other organizations.
Are community-based and faith-based organizations eligible?
Yes. The FOA highlights faith-based or community-based organizations among eligible applicant categories.
Are minority-serving institutions (MSIs) and similar institutions eligible?
Yes. The FOA highlights several categories often central to equity-focused research, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Are U.S. territories or possessions eligible to apply?
Yes. U.S. territories or possessions are listed among eligible applicant categories.
Are federal agencies eligible to apply?
Yes. The FOA includes eligible federal agencies among the highlighted eligible applicant categories.
Are foreign (non-U.S.) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
Can a U.S. organization include a non-domestic component in its application?
No. Non-domestic components of U.S. organizations are not eligible to apply under this opportunity.
Are foreign components allowed in any form?
No. Foreign components (as defined by the NIH Grants Policy) are not allowed.
What is the funding mechanism used for this opportunity?
The opportunity uses the NIH R01 funding instrument and is offered as a discretionary grant program.
Is the award ceiling provided?
No. The provided listing does not specify an award ceiling.
Is the expected number of awards provided?
No. The provided listing does not specify the expected number of awards.
What is the original closing date shown in the source information?
The source data lists an original closing date of 2023-09-07.
When was this opportunity created (per the source information provided)?
The source data lists a creation date of 2020-09-04.
What is the main geographic focus of the research supported by this FOA?
The research is strongly U.S.-focused and emphasizes state and local policy environments within the United States.
What is the core expectation for how research findings should be used?
The program aims to generate practical, policy-relevant evidence that can be used to improve public health outcomes, particularly in places and populations where inequities are most pronounced.
Browse more opportunities from the same category: Education, Health
Next opportunity: NEA Challenge America, FY2022
Previous opportunity: PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 302
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 302) also looked into and applied for these:
| Funding Opportunity |
|---|
| Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) Apply for RFA CA 20 051 Funding Number: RFA CA 20 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) Apply for PAR 20 304 Funding Number: PAR 20 304 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) Apply for RFA CA 20 043 Funding Number: RFA CA 20 043 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Apply for RFA CA 20 046 Funding Number: RFA CA 20 046 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 702 Funding Number: RFA MH 20 702 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 701 Funding Number: RFA MH 20 701 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) Apply for PAR 20 305 Funding Number: PAR 20 305 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,400,000 |
| Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) Apply for PAR 20 310 Funding Number: PAR 20 310 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) Apply for PAR 21 044 Funding Number: PAR 21 044 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) Apply for PAR 20 314 Funding Number: PAR 20 314 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) Apply for PAR 20 313 Funding Number: PAR 20 313 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed) Apply for PAR 21 028 Funding Number: PAR 21 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) Apply for PAR 21 029 Funding Number: PAR 21 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed) Apply for RFA CA 20 054 Funding Number: RFA CA 20 054 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,999 |
| Elucidation of mechanisms underlying complex morbidities of SUD and other mental Illnesses in people living with HIV/AIDS (R01 Clinical Trial Optional) Apply for RFA DA 21 012 Funding Number: RFA DA 21 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA CA 20 056 Funding Number: RFA CA 20 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) Apply for PAR 20 236 Funding Number: PAR 20 236 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Apply for RFA CA 20 055 Funding Number: RFA CA 20 055 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) Apply for RFA CA 20 057 Funding Number: RFA CA 20 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Apply for PAR 21 035 Funding Number: PAR 21 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 302", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
